FDA clears Johnson & Johnson hepatitis C drug

Home › FDA clears Johnson & Johnson hepatitis C drug

The U.S. Food and Drug Administration said Friday it approved the drug, a protease inhibitor that blocks a protein needed by the virus to replicate.

23.11
23.11	NEXT
23.11
23.11	(Rawlings)
23.11	DVD2
23.11
23.11	US Orig LP The Soul Searchers Salt Of ~
23.11	Switch SR SL LED 2
More »

je.st